Search Results - "Visseren, Frank L J"

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials by de Jong, Marit, van der Worp, H Bart, van der Graaf, Yolanda, Visseren, Frank L J, Westerink, Jan

“…Pioglitazone targets multiple pathogenic pathways involved in the development of cardiovascular diseases (CVD). The aim of this systematic review and…”
Get full text

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes by Sharif, Shahnam, Van der Graaf, Y, Cramer, M J, Kapelle, L J, de Borst, G J, Visseren, Frank L J, Westerink, Jan

“…Type 2 diabetes is a condition associated with a state of low-grade inflammation caused by adipose tissue dysfunction and insulin resistance. High…”
Get full text

Association of body mass index and waist circumference with long-term mortality risk in 10,370 coronary patients and potential modification by lifestyle and health determinants by Cruijsen, Esther, Bonekamp, Nadia E, Koopal, Charlotte, Winkels, Renate M, Visseren, Frank L J, Geleijnse, Johanna M

“…Body adiposity is known to affect mortality risk in patients with coronary artery disease (CAD). We examined associations of body mass index (BMI) and waist…”
Get full text

Allopurinol to reduce cardiovascular morbidity and mortality: A systematic review and meta-analysis by van der Pol, Karel H, Wever, Kimberley E, Verbakel, Mariette, Visseren, Frank L J, Cornel, Jan H, Rongen, Gerard A

“…To compare the effectiveness of allopurinol with no treatment or placebo for the prevention of cardiovascular events in hyperuricemic patients. Pubmed, Web of…”
Get full text

Modifiable risk factors in adults with and without prior cardiovascular disease: findings from the Indonesian National Basic Health Research by Arsyad, Dian Sidik, Westerink, Jan, Cramer, Maarten J, Ansar, Jumriani, Wahiduddin, Visseren, Frank L J, Doevendans, Pieter A, Ansariadi

“…The majority of risk factors for cardiovascular diseases (CVDs) are modifiable. Continuous monitoring and control of these factors could significantly reduce…”
Get full text

Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia by Kastelein, John J.P, Akdim, Fatima, Stroes, Erik S.G, Zwinderman, Aeilko H, Bots, Michiel L, Stalenhoef, Anton F.H, Visseren, Frank L.J, Sijbrands, Eric J.G, Trip, Mieke D, Stein, Evan A, Gaudet, Daniel, Duivenvoorden, Raphael, Veltri, Enrico P, Marais, A. David, de Groot, Eric

“…In a 2-year clinical trial, the addition of ezetimibe to simvastatin had no effect on the progression of atherosclerosis, as measured by carotid-artery…”
Get full text

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease by Groenland, Eline H, Vendeville, Jean-Paul, Bots, Michiel L, de Borst, Gert Jan, Nathoe, Hendrik M, Ruigrok, Ynte M, Blankestijn, Peter J, Visseren, Frank L J, Spiering, Wilko

“…Most evidence on the relationship between sodium and potassium intake and cardiovascular disease originated from general population studies. This study aimed…”
Get full text

The readiness of public primary health care (PUSKESMAS) for cardiovascular services in Makasar city, Indonesia by Arsyad, Dian Sidik, Hamsyah, Esliana Fitrida, Qalby, Nurul, Qanitha, Andriany, Westerink, Jan, Cramer, Maarten J, Visseren, Frank L J, Doevendans, Pieter A, Ansariadi, Ansariadi

“…The increasing burden of cardiovascular disease (CVD) has become a major challenge globally, including in Indonesia. Understanding the readiness of primary…”
Get full text

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease by Jagt, Vivianne L, Hazenberg, Constantijn E V B, Kapelle, Jaap, Cramer, Maarten J, Visseren, Frank L J, Westerink, Jan

“…The ankle brachial index (ABI) can be used to diagnose peripheral arterial disease (PAD). The clinical relevance of the ABI, especially in patients with known…”
Get full text

Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP by Matsushita, Kunihiro, Kaptoge, Stephen, Hageman, Steven H J, Sang, Yingying, Ballew, Shoshana H, Grams, Morgan E, Surapaneni, Aditya, Sun, Luanluan, Arnlov, Johan, Bozic, Milica, Brenner, Hermann, Brunskill, Nigel J, Chang, Alex R, Chinnadurai, Rajkumar, Cirillo, Massimo, Correa, Adolfo, Ebert, Natalie, Eckardt, Kai-Uwe, Gansevoort, Ron T, Gutierrez, Orlando, Hadaegh, Farzad, He, Jiang, Hwang, Shih-Jen, Jafar, Tazeen H, Jassal, Simerjot K, Kayama, Takamasa, Kovesdy, Csaba P, Landman, Gijs W, Levey, Andrew S, Lloyd-Jones, Donald M, Major, Rupert W, Miura, Katsuyuki, Muntner, Paul, Nadkarni, Girish N, Nowak, Christoph, Ohkubo, Takayoshi, Pena, Michelle J, Polkinghorne, Kevan R, Sairenchi, Toshimi, Schaeffner, Elke, Schneider, Markus P, Shalev, Varda, Shlipak, Michael G, Solbu, Marit D, Stempniewicz, Nikita, Tollitt, James, Valdivielso, José M, van der Leeuw, Joep, Wang, Angela Yee-Moon, Wen, Chi-Pang, Woodward, Mark, Yamagishi, Kazumasa, Yatsuya, Hiroshi, Zhang, Luxia, Dorresteijn, Jannick A N, Di Angelantonio, Emanuele, Visseren, Frank L J, Pennells, Lisa, Coresh, Josef

“…The 2021 European Society of Cardiology (ESC) guideline on cardiovascular disease (CVD) prevention categorizes moderate and severe chronic kidney disease (CKD)…”
Get full text

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis by Groenhof, T Katrien J, Asselbergs, Folkert W, Groenwold, Rolf H H, Grobbee, Diederick E, Visseren, Frank L J, Bots, Michiel L

“…Cardiovascular risk management (CVRM) is notoriously difficult because of multi-morbidity and the different phenotypes and severities of cardiovascular…”
Get full text

Risk Factor Clusters and Cardiovascular Disease in High-Risk Patients: The UCC-SMART Study by Holthuis, Emily I, Visseren, Frank L J, Bots, Michiel L, Peters, Sanne A E

“…Clustering of vascular risk factors, i.e., the co-existence of two or more risk factors, has been associated with a higher risk of cardiovascular disease (CVD)…”
Get full text

Relation of Epicardial and Pericoronary Fat to Coronary Atherosclerosis and Coronary Artery Calcium in Patients Undergoing Coronary Angiography by Gorter, Petra M., MD, PhD, de Vos, Alexander M., MD, van der Graaf, Yolanda, MD, PhD, Stella, Pieter R., MD, Doevendans, Pieter A., MD, PhD, Meijs, Matthijs F.L., MD, Prokop, Mathias, MD, PhD, Visseren, Frank L.J., MD, PhD

“…Fat surrounding coronary arteries might aggravate coronary artery disease (CAD). We investigated the relation between epicardial adipose tissue (EAT) and…”
Get full text

Routinely measured hematological parameters and prediction of recurrent vascular events in patients with clinically manifest vascular disease by Kofink, Daniel, Muller, Steven A, Patel, Riyaz S, Dorresteijn, Jannick A N, Berkelmans, Gijs F N, de Groot, Mark C H, van Solinge, Wouter W, Haitjema, Saskia, Leiner, Tim, Visseren, Frank L J, Hoefer, Imo E, Asselbergs, Folkert W

“…The predictive value of traditional risk factors for vascular events in patients with manifest vascular disease is limited, underscoring the need for novel…”
Get full text

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease by Smidt, Lisanne C A, Visseren, Frank L J, de Ranitz-Greven, Wendela L, Nathoe, Hendrik M, Kappelle, L Jaap, de Borst, Gert J, de Valk, Harold W, Westerink, Jan

“…Recent treatment guidelines support the use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) in patients with type 2 diabetes and cardiovascular disease…”
Get full text

Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease by van de Woestijne, Anton P, van der Graaf, Yolanda, de Bakker, Paul I W, Asselbergs, Folkert W, Spiering, Wilko, Visseren, Frank L J

“…Single nucleotide polymorphisms in the APOA5-A4-C3-A1 gene complex are associated with elevated plasma triglycerides and elevated vascular risk in healthy…”
Get full text

Perivascular adipose tissue as a cause of atherosclerosis by Verhagen, Sandra N, Visseren, Frank L.J

“…Abstract Perivascular adipose tissue surrounds (coronary) arteries and may be involved in local stimulation of atherosclerotic plaque formation. Epicardial…”
Get full text

Low High-Density Lipoprotein Cholesterol Is Not a Risk Factor for Recurrent Vascular Events in Patients With Vascular Disease on Intensive Lipid-Lowering Medication by van de Woestijne, Anton P., MD, van der Graaf, Yolanda, MD, PhD, Liem, An-Ho, MD, PhD, Cramer, Maarten J.M., MD, PhD, Westerink, Jan, MD, PhD, Visseren, Frank L.J., MD, PhD

“…Objectives This study sought to evaluate the vascular risk of low high-density lipoprotein-cholesterol (HDL-C) in relation to the use and intensity of…”
Get full text

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes by van der Leeuw, Joep, Visseren, Frank L. J., Woodward, Mark, van der Graaf, Yolanda, Grobbee, Diederick E., Harrap, Stephen, Heller, Simon, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Zoungas, Sophia, Chalmers, John

“…Aims/hypothesis Intensive glucose control reduces the risk of vascular complications while increasing the risk of severe hypoglycaemia at a group level. We…”
Get full text

Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions by Biessels, Geert Jan, Prof, Strachan, Mark W J, Prof, Visseren, Frank L J, Prof, Kappelle, L Jaap, Prof, Whitmer, Rachel A, PhD

“…Summary Type 2 diabetes is associated with dementia, and also with more slight cognitive decrements. In this Review we discuss trajectories from normal…”
Get full text